PAM Theragnostics
Latest round
- Series A
Last raised
- Nov 2021
Total raised
- $1.7M
Investors
- 1
About PAM Theragnostics
Based in Berlin, Germany, and founded in 2020 by Dr. Andreas Bergmann, PAM Theragnostics GmbH is a research-based company engaged in the development of therapeutic and diagnostic approaches for diseases related to the maturation of the body's amidated peptide hormones. PAM Theragnostic's team of R&D scientists researches the human body's PAM enzyme and its role in detecting Alzheimer's Disease in patients. PAM Theragnostics intends to use its research on the PAM enzyme to develop tools for the early diagnosis of Alzheimer's Disease and develop a therapy for Alzheimer's patients.
Who invested in PAM Theragnostics
1 investor across 1 round
See all investors in PAM Theragnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 24, 2021
Amount
$1.7M
Investors
Questions about PAM Theragnostics
Who invested in PAM Theragnostics?
PAM Theragnostics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PAM Theragnostics raised?
PAM Theragnostics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did PAM Theragnostics last raise money?
PAM Theragnostics's most recent round on record is a Series A, in Nov 2021.
What does PAM Theragnostics do?
Based in Berlin, Germany, and founded in 2020 by Dr.
Where is PAM Theragnostics headquartered?
PAM Theragnostics is headquartered in Berlin, Germany.
Which VCs invest in companies like PAM Theragnostics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back medical devices & equipment companies at PAM Theragnostics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like PAM Theragnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.